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Monoclonal  antibodies  and  receptor  ligands  can  deliver  covalently coupled 
toxic ricin  A  chain  to  selected  cell  membrane  targets  but,  for cytotoxicity to 
result, internalization and passage into the cytosol must also ensue. This prereq- 
uisite  binding  and  entry,  which  allows  A  chain  to  come  in  contact  with  and 
enzymatically inactivate ribosomes (1), also provides a safeguard against affecting 
innocent bystander cells that lack the appropriate receptor or antigen. We have 
constructed a toxic conjugate composed of human transferrin disulfide linked to 
ricin A chain (TF-A chain) ~ so that this receptor-mediated iron delivery pathway 
can be used to explore the more subtle aspects of A chain intoxication (2). While 
passage of transferrin into and back out of cells occurs in a matter of minutes (3, 
4), the toxic conjugate required 6 h to inhibit cellular protein synthesis (2). This 
indicated that its speed of action was dictated by some slow or infrequent event 
divorced from the  normal  cycle. Therefore, we  tested TF-A chain along with 
the carboxylic ionophores monensin and nigericin, which can raise the pH and 
otherwise disturb the stability of vesicle compartments within the cell (5). In the 
presence of ionophore, inhibition of protein synthesis by TF-A chain was accel- 
erated  15-fold,  occurring  with  a  half-time  (tl/2)  of only 24  min.  Potency was 
correspondingly  raised  by  several  orders  of  magnitude  and  the  number  of 
receptor sites required for toxicity was also dramatically reduced. Ricin A  chain 
delivered into  cells by a  monoclonal antibody directed against  common acute 
lymphoblastic  leukemia  antigen  (CALLA)  determinants  (6)  responded  to  the 
potentiating influences of carboxylic ionophores in a similar manner. 
Materials and Methods 
Toxic Conjugates.  Purified ricin A chain was disulfide linked to either human transfer- 
rin or mouse monoclonal antibodies and the composition of these conjugates was analyzed 
as previously described (2, 6). Membrane-localized ricin A chain was detected on conju- 
gate-treated  cells  using  a  fluoresceinated monoclonal anti-A  chain  antibody (7)  and 
fluorescence-activated cell sorter (FACS) analysis. 
Cells.  K562, a human erythroleukemia cell line (8) was maintained and used in serum- 
free media (2). The human leukemia CEM cell line and a variant TF-A chain-resistant 
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CEM cell line were obtained and grown in culture as reported (2). Nalm-6, a CALLA- 
positive human acute lymphoblastic leukemia line as well as the CALLA-negative leukemic 
T cell, HSB-2, and myeloid, HL-60, lines were used as previously described (6). 
Cytotoxicity.  Cells in appropriate media were plated in tissue culture wells (1.7  x  1.6 
cm)  at  an  initial  concentration  of 40  x  104  cells/ml.  Monensin  and  nigericin  were 
purchased from Sigma Chemical Co., St.  Louis, MO and were diluted into media from 
stock solutions at 10  -2 M in absolute ethanol. Designated amounts of toxic conjugates and 
ionophore were added to the  1 ml cultures and the  cell  number was  microscopically 
evaluated on a daily basis (9). Growth of CEM cells was slowed by monensin (see Table I) 
but this effect could be avoided if,  after overnight treatment, they were washed and 
resuspended in fresh media (see  Fig.  3).  Specific  blocking studies were carried out by 
putting an excess of iron-saturated transferrin or monoclonal antibody in the cultures just 
before adding conjugate. Inhibition of cellular protein synthesis was evaluated using a 30- 
min pulse of [~4C]leucine; incorporation into protein was measured as previously described 
(9). Kinetic studies were performed by treating cells with 10  -7 M TF-A chain for 10 min 
with or without monensin at 10  -7 M and then adding excess transferrin (10 -~ M) to block 
further binding. The cells were then further incubated for various times before measuring 
protein synthesis (9). Identically treated ceils that received excess transferrin before the 
addition of TF-A chain served as a control. 
Results and Discussion 
Given the demonstration that a  single toxic A  chain molecule is lethal when 
properly situated within the cell (10,  11), a disproportionate excess of membrane- 
bound toxin is usually required to cause cell death. This is especially true when 
alternative carriers are deployed in place of the natural binding moiety (2). The 
time required for such toxins to affect cells is typically several hours even when 
all  surface  antigen  or  receptor  sites  are  saturated  by  antibody  and  ligand- 
delivered  A  chain  (2,  9,  12).  Such  was  the  case,  we  found,  for  the  receptor- 
mediated toxicity of TF-A chain on both human T  cell leukemia CEM (2) and 
erythroleukemia K562  cells in  culture.  A  loss of the cells ability to synthesize 
protein signals the arrival of this toxin into the cytoplasm, where it inactivates 
ribosomes, and the kinetics of this inhibition under receptor-saturating conditions 
is characterized by a t~/~ of 375 min (Fig.  1). To reach its intracellular target, we 
anticipated  that  TF-A  chain  would  have  to  escape  from  the  normal  cycling 
pathway of transferrin  entry  into  and  exit  from  the  cell  (3,  4).  This  process 
involves passage into various compartments, the pH of which is important. We 
therefore tested the speed of TF-A chain action in the presence of carboxylic 
ionophores,  which  disturb  the  acidification  and  normal  functioning of these 
vesicles. 
A  15-fold rate increase was observed when monensin was included with TF-A 
chain (Fig.  1) and the t~/2  (24 min) was much closer to what would be expected 
from the known speed of entry of receptor-bound  transferrin into cells (3,  4). 
Monensin exerted this influence on protein synthesis only in concert with TF-A 
chain, suggesting that ionophore facilitates the access of A  chain to ribosomes. 
Accelerated release from vesicles is a  possible mechanism but alternative expla- 
nations are plausible. To determine the exposure time required for toxicity to 
occur,  TF-A  chain  was  mixed  with  K562  cells  and,  after different intervals, 
excess transferrin was added to stop further binding to the receptor. TF-A chain 
that had become attached or internalized during this time was then allowed to 
act for 2  h in the presence of ionophore or 20 h in its absence before measuring 1236  IONOPHORE POTENTIATION OF  TOXIC  A  CHAIN  CONJUGATES 
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FIGURE 1.  Kinetics for inhibition  of cellular protein synthesis by TF-A chain.  Receptor sites 
were saturated by treating K562 cells with 10  -7 M TF-A chain for 10 min and then transferrin 
was added at  10  -5 M to block toxin interaction with recycled receptor. The cells were then 
incubated for designated  intervals  at 370C in leucine-free  media alone (A) or with  10  -7 M 
monensin  ((3) before pulsing  with  [~4C]leucine (30  min) and assaying incorporation. When 
excess  transferrin  was  added  before TF-A  chain  exposure,  levels of incorporation  were 
comparable to untreated cells and this served as a control for each time point. 
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FIGURE 2.  Exposure time required for toxicity. The interaction of K562 cells with  10  -7 M 
TF-A chain was stopped at different times by adding a 100-fold excess of  transferrin; incubation 
at 37°C proceeded for an additional  20 h in media alone (A) or 2 h in media with  10  -7 M 
monensin (O). The cells were then pulsed  with [~4C]leucine (30 min) and incorporation was 
compared with 0 time controls that were preblocked with transferrin (10 -5 M) before addition 
of toxin. 
protein synthesis. Cells were progressively affected as the exposure time increased 
(Fig. 2) and one-half of the cells had already bound or taken up a  lethal amount 
by 50 s.  When ionophore was omitted, a prolonged postincubation was required 
for TF-A chain to produce its effect and the shift in this curve (Fig.  2) suggests 
that bound toxin was not completely retained  in the cell during this period. 
Human  leukemia  CEM  cells  express  high  levels  of transferrin  receptor  and 
their growth and viability is correspondingly affected by low doses of TF-A chain 
(Fig. 3) (2).  When  10 nM monensin was included in the culture media, however, 
the dose response curve was dramatically shifted to 30,000 times greater potency 
(Fig. 3), and 50% kill was achieved by adding only five molecules of TF-A chain 
for each cell. The potency of this toxic conjugate on CEM cells when assisted by 
ionophore  (IDs0 =  3  ×  10  -15 M) was greater  than  that of native  ricin,  which is 
required at  1,000-fold higher levels to produce comparable cytotoxicity (2). RASO  AND  LAWRENCE  1237 
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FIGURE 3.  Toxicity dose response curves for TF-A chain on CEM cells in the presence and 
absence of ionophore. CEM  cells in  media alone  or  media containing  10  -s  M  monensin 
received the designated concentrations of TF-A chain. After overnight incubation at 37°C, 
the cells were washed, resuspended in media alone, and plated in tissue culture wells.  The 
number of viable cells was evaluated on day 3. 
It  is  important  to determine  if the action  of free A  chain  or whole ricin  is 
comparably influenced by ionophore.  Pure ricin A chain is toxic to CEM cells at 
10 -6 M (2), indicating that at high concentrations there is nonspecific uptake of 
small amounts that can reach the ribosomes. In the presence of 10 nM monensin, 
a  I0  -s M  level of free A  chain  was sufficient to kill these cells and a  500-fold 
excess of monoclonal anti-A chain but not anti-=B chain blocked this cytotoxicity. 
The data  suggests that  free A  chain  follows a  similar  intracellular  pathway to 
that of ligand-delivered A chain, albeit with much lower internalization efficiency. 
The cytotoxicity of whole ricin  for CEM cells was only modestly improved by 
using monensin (data not shown). 
A previously isolated variant CEM cell line, displaying 1,000-fold resistance to 
TF-A chain,  had  a  greatly  diminished  capacity for binding  transferrin  (2,  13) 
and this phenotypic defect allowed them to survive toxin treatment.  The influ- 
ence of ionophore on the time course of TF-A chain cytotoxicity was assessed 
using both the sensitive and resistant cell lines to see if they responded similarly 
(Table I). The potentiation provided by ionophore promoted more rapid lysis of 
sensitive CEM cells and was also able to override the resistance that reduced TF- 
A  chain  binding  afforded the  variant  line.  The  inclusion  of a  300-fold molar 
excess  of  unmodified  human  transferrin  forestalled  the  combined  cytotoxic 
effects of TF-A  plus  ionophore  chain  seen  on  day  1,  but  this  blockade  was 
gradually overcome by day 3 (data not shown). Since the cytotoxicity of TF-A 
chain  alone  is totally blocked by this  treatment  (2),  it appears  that  ionophore 
reveals the  few molecules that  do eventually enter the cell in  the  presence of 
excess transferrin.  NH4CI included in culture medium at  10 -~ M failed to show 
effects comparable to those seen with ionophore (data not shown) even though 
this agent can raise vesicle pH values and influences cytotoxicity in other delivery 
systems (14). These results indicate that ionophore-assisted TF-A chain toxicity 
is still receptor mediated and that cells which bind only miniscule amounts of the 
toxin can be killed when ionophore is present. 
A  monoclonal  antibody-ricin  A  chain  conjugate developed to  kill  CALLA- 
bearing cells was shown to be highly specific but produced only partial inhibition 1238  1ONOPHORE  POTENTIATION  OF  TOXIC  A  CHAIN  CONJUGATES 
TABLE  I 
Effect of lonophore on TF-A Chain-sensitive and -resistant CEM 
Cells 
Cell number per milliliter (× 10-4) * 
Day 1  Day 2  Day 3 
Sensitive CEM  59  106  208 
Plus TF-A*  34  7  0 
Sensitive CEM +  monensin  !  60  74  154 
Plus monensin +  TF-A  0  0  0 
Resistant CEM  50  80  160 
Plus TF-A  53  68  178 
Resistant CEM +  monensin  42  60  92 
PLus monensin +  TF-A  19  1  0 
* Started at 40 ×  104 cells/ml. 
* TF-A chain at 10 -9 M. 
|  Monensin at  10 -s M, 
TABLE  II 
Cytotoxicity  of Anti-CALLA-Ricin  A Chain 
Anti-CALLA-  Anti-CALLA-  Ionophore  Plus excess  CALLA  Cells alone*  A chain  (10  -8 M)  A chain +  antibody* 
Cell line  expression  (day 3)  (10  -9 M)  ionophore 
Nalm 6  ++++  247  80  215  0  234 
CEM  :t:  436  439  222  34  226 
HSB2  -  242  --  220  242  -- 
HL60  -  118  --  106  108  -- 
* Cell number/ml (×10-4); cells were started at 40 ×  104/ml. 
* Monoclonal anti-CALLA at 1 ×  10  -6 M. 
of protein synthesis in target cells (6).  Its presence in culture medium for 2 d or 
more was required to totally suppress cell proliferation (6).  At that time, agents 
such as  NH4CI,  chloroquine,  and  dansylcadaverine  were tested in  attempts  to 
accelerate anti-CALLA-A  chain  action  but none  produced significant  results. 
The enhancement  conferred by carboxylic ionophores on transferrin  receptor- 
mediated A chain toxicity prompted the trial of these same agents for promoting 
CALLA-mediated  delivery into  the  cytosol.  In  fact  the anti-CALLA-A  chain 
conjugate plus monensin  or nigericin  gave 95%  inhibition  of protein  synthesis 
when  incubated  for  only  3  h  with  CALLA-positive  Nalm  6  cells,  whereas 
conjugate alone or conjugate with 10 mM NH4CI gave only a 30-40% reduction. 
It was anticipated  that  this potentiation  by ionophore would greatly  influence 
the  speed and  extent  of cell  kill  as well as the amount  of CALLA expression 
required  to produce cytotoxicity. To test this,  the viability of cell lines having 
different amounts of CALLA on their membrane was examined after treatment 
using the  antibody-A chain  conjugate  with  and  without  monensin  (Table  II). 
Nalm  6  cells  strongly  expressed  CALLA  and  bound  a  substantial  amount  of 
antibody-A chain; however, even though their growth was reduced over 3 d by 
10 -9 M conjugate, complete cell kill was not achieved (6) (Table II). Proliferation 
of these cells remained  unaffected by monensin alone but, when a combination 
of ionophore plus toxin was used, no cells were present on day 3 and in fact all RASO AND LAWRENCE  1239 
cells  had  lysed  1  d  after  treatment.  This  cytotoxicity was  entirely  CALLA 
mediated and  could be prevented when all  antigen sites were blocked by an 
excess of unmodified monoclonal anti-CALLA antibody (Table II). 
The amount of anti-CALLA-A chain bound by CEM cells was barely detect- 
able  using  a  fluoresceinated monoclonal anti-A  chain  probe  and  analysis by 
cytofluorimetry. In accordance with the low level of target antigen, their growth 
was not affected by antibody-A chain conjugate at 10 -9 M (Table II) or even as 
high as  10 -7 M (8).  This is in striking contrast to their response to TF-A chain 
(Fig. 3), where the abundance of transferrin receptor makes them highly suscep- 
tible.  The  combined effects of ionophore and  the CALLA-specific conjugate 
overcame this antigen deficiency to produce significant toxicity (Table II). Once 
again, the inclusion of excess uncoupled antibody rescued these cells from the 
action of ionophore plus toxin and established specificity (Table II). Growth of 
the CALLA-negative HL60 and HSB-2 lines remained unaffected by conjugate 
with ionophore (Table II) and this persisted even when  10 -7 M  levels of anti- 
CALLA-A chain were tested. 
The  vast diversity in  expression  of surface receptors and antigens offers a 
means of distinguishing various cell types and the selective toxicity of A  chain 
conjugates is based upon this feature. It has been apparent for some time now 
that the full toxic potential of these new conjugates has not been realized, due 
to their slow or inefficient passage into the cytosol. An ability to manipulate the 
intracellular aspects of the intoxication process is therefore important so that the 
speed of action and potency of these toxins can be controlled. Various agents 
including N H4CI (14), chloroquine (15), adenovirus (16), and ricin B chain (12, 
17)  have  been  used  to  potentiate  toxic  activity.  The  carboxylic  ionophores 
examined in this work, however, possess some unique properties and advantages. 
They act catalytically and are therefore effective at much lower concentrations 
than  NH4CI  or chloroquine.  Ricin A  chain delivery systems, which have been 
reticent to potentiation by other agents, may be appreciably enhanced by car- 
boxylic ionophores. Moreover, the observed increases in rate of cell kill, conju- 
gate potency, and cell susceptibility to toxic action have been pronounced. 
Summary 
The highly selective cytotoxicity of site-directed ricin A chain conjugates can 
be potentiated by membrane-active carboxylic ionophores. The combined use of 
the two agents results in much faster inactivation of ribosomes and subsequent 
cell  death  and  lysis.  The  potency  of A  chain  cytotoxins  is  correspondingly 
increased by  several  orders of magnitude and  cells  that  sparsely express  the 
target antigen or receptor can be killed. 
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